First-of-its-Kind stem cell injection tested to halt worsening MS
NCT ID NCT06841068
Summary
This study aimed to test the safety and potential benefits of a new stem cell therapy for people with progressive multiple sclerosis (MS). Researchers planned to inject stem cells from amniotic fluid directly into the spinal fluid of participants over a year. The goal was to see if this approach could safely slow or improve the worsening disability seen in progressive forms of MS.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, PROGRESSIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health
Charlotte, North Carolina, 28204, United States
Conditions
Explore the condition pages connected to this study.